MicroTech Medical (Hangzhou) Co., Ltd. Class H (HK:2235) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
MicroTech Medical (Hangzhou) Co., Ltd. has announced that its Board of Directors will convene on August 30, 2024, to review and approve the unaudited interim financial results for the first half of the year ending June 30, 2024. The meeting will also consider the potential declaration of an interim dividend. This forthcoming Board meeting signals critical financial updates and possible shareholder returns from the healthcare technology firm.
For further insights into HK:2235 stock, check out TipRanks’ Stock Analysis page.

